Share Share on Facebook Share on Twitter Pinterest Email Radiopharm Theranostics (RAD:AU) has announced First patient dosed in Phase IIb imaging for Brain Mets Download the PDF here. This post appeared first on investingnews.com admin Website Prev Post Binding Commitments Received for A$1.0 Million under Convertible Note Placement April 28, 2025 Next Post S&P 500 Rises from Bearish to Neutral, But Will It Last? April 28, 2025 Related Posts Fund Manager: Gold Stocks a Strategic Opportunity for Investors May 21, 2025 Lode Gold Leverages Artificial Intelligence to Drive Exploration and Growth in Yukon May 21, 2025 TSX Hits Record High Amid Gold Price Surge and Easing Trade Tensions May 21, 2025